CLuB Presents at the Trinity St James’s Cancer Institute (TSJCI) Research Day 2024

The Trinity St James’s Cancer Institute (TSJCI) held its 2nd Research Day on September 17th in MISA’s Davis Coakley seminar room.  The event was an internal forum to highlight the depth and breadth of cancer research across Trinity College Dublin and St James’s Hospital and to bring people together to share ideas and foster new collaborations.  CLuB’s Founder & Lead Investigator and TSJCI Research Lead, Professor Lorraine O’Driscoll, opened the event. Professor O’Driscoll also co-chaired the session on Molecular and Precision Oncology.

Professor Lorraine O’Driscoll opening the TSJCI Research Day

CLuB’s Post-Doctoral Researcher, Dr Ezgi Oner, delivered a presentation on “3D Bioprinted Patient-Derived Lung Cancer Models: Bridging the Gap Between Laboratory Research and Personalized Therapy”.

Dr Ezgi Oner

During the event, Ms. Volga M. Saini, CLuB PhD candidate, presented on the topic "Comparison of Different Circulating Tumour Cell (CTC) Enrichment Technologies and Enumeration of CTCs in Patients with Resectable Lung Cancer," while Ms. Faye Lewis, also a CLuB PhD candidate, discussed "Does size matter for liquid biopsies in epithelial ovarian cancer?"

Professor Gerry Hanna and Ms Volga M. Saini during the session on Molecular and Precision Oncology

CLuB’s esteemed colleague Dr Mark Ward presented “Using liquid biopsy to better understand immunotherapy and antibody-drug conjugates in triple-negative breast cancer.”

Professor Lorraine O'Driscoll and Dr Mark Ward























Previous
Previous

CLuB Founder & Lead Investigator is an Invited International Expert & Plenary Speaker at the GMCRT-2024, Valencia

Next
Next

CLuB Presents at The All-Ireland Schools of Pharmacy Annual Research Conference 2024 at RCSI, Dublin